In a 2014 clinical study, the longer dwell time§ of Nexiva™ Catheter System led to a cost reduction of approximately $1 million per year per 1,000 beds compared with an open system.7
Enhance patient care with
an all-in-one closed IV
catheter system
BD Nexiva™ Closed IV Catheter System is part of a broad portfolio of closed, integrated peripheral IV catheters (PIVCs) designed with the patient and clinician experience in mind.
Overall clinician satisfaction has been shown to be significantly higher with Nexiva™ Catheter System compared to a non-integrated, open PIVC.*,1
The integrated system is designed with clinician safety in mind:
*compared to a non-integrated PIVC in a clinical study
See the power of a closed
catheter system
Watch this video to see the differences in design between the integrated Nexiva™ Catheter System and a non-integrated PIVC without blood control technology, which can risk missed insertion, blood leakage, or touch contamination.
Complications may compromise patient care and increase cost, including interrupting drug administration, delaying procedures, and removing and reinserting a new catheter, increasing the risk of catheter failure with each subsequent insertion.4–6
Nexiva™ Catheter System has been clinically demonstrated to significantly reduce catheter-related complications in a number of studies:2,7
†BD Nexiva Closed System with 3M™ Tegaderm IV Securement Dressing compared to
B. Braun Introcan Safety® Catheter with Statlock® IV Ultra Stabilization Device and non-bordered dressing.
‡ with a PTFE catheter
In a 2014 clinical study, the longer dwell time§ of Nexiva™ Catheter System led to a cost reduction of approximately $1 million per year per 1,000 beds compared with an open system.7
Longer median dwell time compared to an open system4,7
Nexiva™ Catheter System eliminates the need to purchase many separate components. Every Nexiva™ Catheter System contains a pre-attached extension tube and built-in stabilization platform. Nexiva™ Catheter System is offered in configurations containing BD MaxZero™ Needle-free Connectors and BD Q-Syte™ Needle-free Connectors.
§compared to an open system
IV catheter failure rates lie between 35% and 50%. Compounding this issue, subsequent PIVCs inserted after treatment failure are more likely to fail again, potentially perpetuating the challenges and dissatisfaction for the patient.6
Higher first attempt insertion success may be a relief to patients. Studies have shown:
Nexiva™ Catheter System is offered in four configurations. The dual port configurations allow for the simultaneous administration of two compatible solutions as close to the patient as possible. The single port configurations allow for the administration of one solution, as is common with most PIVCs.
Nexiva™ Catheter System is offered in configurations containing BD MaxZero™ Needle-free Connectors and BD Q-Syte™ Needle-free Connectors. MaxZero™ Needle-free Connectors are premium needle-free connectors and are offered on both dual port and single port configurations. BD Q-Syte™ Needle-free Connectors are also offered on dual port configuration.
BD-3595 (07/24)
Nexiva™ Catheter System has been shown to deliver higher clinician satisfaction, improved clinician safety and a reduction in overall complication rates versus non-integrated, open systems.1–3
Nexiva™ Catheter System is backed by evidence in peer-reviewed journals from as early as 20094 to as recently as 2024.5
Nexiva™ Diffusics Closed IV Catheter System is also backed by peer-reviewed journals and infusion guidelines. Infusion Therapy Standards of Practice state to consider a fenestrated catheter for a contrast-based radiographic study and in coronary CTA.6 Nexiva Diffusics™ Catheter System is the only peripheral IV catheter with a diffusion catheter tip specifically designed for power injection.
Closed IV Catheter
| Comparative
| Data gathered | Year
| Study type | Journal | Authors |
Nexiva™ | Various | Catheter failure, dislodgement, occlusion, phlebitis | 2024 | Systematic review/ meta analysis5 | Journal of Vascular Access | Gidaro A, Quici M, Giustivi D, et al. |
Nexiva™ | BD Insyte Autoguard™ | Complications, dislodgement, dwell time, infiltration, occlusion, phlebitis | 2023 | RCT7 | European Journal of Oncology Nursing | Gerceker GO,
Yildirim BG, Onal A, et al. |
Nexiva™ | B. Braun
BD Insyte | Catheter-associated bloodstream infection, clinician satisfaction, cost savings/utilization reduction, dislodgement/ leaking, dwell time, infiltration/extravasation, local infection, insertion success, occlusion, phlebitis | 2022 | RCT1 | Journal of Hospital Medicine | Rickard CM,
Larsen E, Walker RM, et al. |
Nexiva™ | Smiths Jelco ProtectIV® Plus | Clinician satisfaction, dwell time, infection, infiltration, pain, phlebitis | 2019 | Prospective, quasi-experimental8 | Journal of Infusion Nursing | Penoyer D, Fowler S, Bennett M |
Nexiva™ | None | Blood exposure, dislodgement, kinking, leaking, phlebitis, restarts | 2017 | Observational9 | Journal of Vascular Access | deRosenroll A |
Nexiva™ | Medikit | Bending and kinking, blood exposure, cost savings/utilization reduction,dislodgement, dwell time, extravasation, insertion success, obstruction, phlebitis | 2014 | Quasi- randomized study10 | Journal of Vascular Access | Tamura N, Abe S, Hagimoto K, et al. |
Nexiva™ | B. Braun Vasocan® Safety | Catheter-related infection, cost savings/utilization reduction, dwell time, infiltration/extravasation, insertion success, occlusion, pain, painful hematoma, phlebitis | 2014 | RCT2 | Journal of Hospital Infection | González López J, Arribi Vilela A, Fernández Del, Palacio E, et al. |
Nexiva™ | B. Braun Introcan Safety® (non- winged) with StatLock | Clinician satisfaction, cost savings/utilization reduction, dislodgement, dwell time, infiltration, insertion success, leaking, phlebitis | 2010 | RCT3 | Journal of Infusion Nursing | Bausone-Gazda D, Lefaiver CA, Walters SA, et al. |
Nexiva™ | None | Clinician satisfaction, clotting, dislodgement, infiltration, leaking, restarts, securement | 2009 | Pre-and post-use survey4 | Journal of the Association of Vascular Access | McNeil E, Hines N, Phariss R |
Catalog no. | Color | Gauge | Catheter
| Gravity flow rate
| Maximum power
|
383571 | Yellow | 24 | 0.75 | 18 | Not for use with power injectors |
383572 | Blue | 22 | 1.00 | 33 | 3.0 |
383573 | Blue | 22 | 1.75 | 30 | 3.0 |
383576 | Pink | 20 | 1.00 | 61 | 4.0—5.5 |
383577 | Pink | 20 | 1.25 | 58 | 4.0—5.5 |
383578 | Pink | 20 | 1.75 | 51 | 4.0—5.5 |
383579 | Green | 18 | 1.25 | 84 | 4.0—7.0 |
383580 | Green | 18 | 1.75 | 79 | 4.0—7.0 |
*22–18 G BD Nexiva™ Catheter System—Dual Port with BD MaxZero™ Needle-free Connectors attached are suitable for use with power injection. The catheter system has been tested at flow rates; however, due to variations in add-on devices, tubing, contrast media temperature and pressure limit settings these flow rates may not be achievable.
Catalog no. | Color | Gauge | Catheter
| Gravity
| Max power
|
383550 | Yellow | 24 | 0.56 | 19 | Not for use with power injectors |
383551 | Yellow | 24 | 0.75 | 18 | Not for use with power injectors |
383552 | Blue | 22 | 1.00 | 33 | 3.0 |
383553 | Blue | 22 | 1.75 | 30 | 3.0 |
383556 | Pink | 20 | 1.00 | 61 | 4.0—5.5 |
383557 | Pink | 20 | 1.25 | 58 | 4.0—5.5 |
383558 | Pink | 20 | 1.75 | 51 | 4.0—5.5 |
383559 | Green | 18 | 1.25 | 84 | 4.0—7.0 |
393560 | Green | 18 | 1.75 | 79 | 4.0—7.0 |
*22–18 G BD Nexiva™ Catheter System — Single Port with BD MaxZero™ Needle-free Connectors attached are suitable for use with power injection. The catheter system has been tested at flow rates; however, due to variations in add-on devices, tubing, contrast media temperature and pressure limit settings these flow rates may not be achievable.
Catalog no. | Color | Gauge | Catheter
| Gravity flow rate
| Maximum power
|
383530 | Yellow | 24 | 0.56 | 19 | Not for use with power injectors |
383531 | Yellow | 24 | 0.75 | 18 | Not for use with power injectors |
383532 | Blue | 22 | 1.00 | 33 | 3.0 |
383536 | Pink | 20 | 1.00 | 61 | 4.0—5.5 |
383537 | Pink | 20 | 1.25 | 58 | 4.0—5.5 |
383538 | Pink | 20 | 1.75 | 51 | 4.0—5.5 |
383539 | Green | 18 | 1.25 | 84 | 4.0—7.0 |
383540 | Green | 18 | 1.75 | 79 | 4.0—7.0 |
*BD Q-Syte™ Needle-free Connectors must be removed prior to power injection. The catheter system has been tested at flow rates; however, due to variations in add-on devices, tubing, contrast media temperature and pressure limit settings these flow rates may not be achievable.
Catalog no. | Color | Gauge | Catheter
| Gravity flow rate
| Maximum power
|
383510 | Yellow | 24 | 0.56 | 19 | Not for use with power injectors |
383511 | Yellow | 24 | 0.75 | 18 | Not for use with power injectors |
383512 | Blue | 22 | 1.00 | 33 | 3.0 |
383513 | Blue | 22 | 1.75 | 30 | 3.0 |
383516 | Pink | 20 | 1.00 | 61 | 4.0—5.5 |
383517 | Pink | 20 | 1.25 | 58 | 4.0—5.5 |
383518 | Pink | 20 | 1.75 | 51 | 4.0—5.5 |
383519 | Green | 18 | 1.25 | 84 | 4.0—7.0 |
383520 | Green | 18 | 1.75 | 79 | 4.0—7.0 |
*The catheter system has been tested at flow rates; however, due to variations in add-on devices, tubing, contrast media temperature and pressure limit settings these flow rates may not be achievable.
Find our training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Find our training resources to help improve your clinical practices as part of our goal of advancing the world of health.